EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Management of iron deficiency anemia and the role of intravenous iron supplementation in patients undergoing cancer chemotherapy: a real-world retrospective study in Japan

Miyako Kosugi, Ryo Takezawa, Shun Shiota, Shoichiro Inokuchi, Hirokazu Takaya, Masami Yamauchi

International Journal of Clinical Oncology · 2026

DOI: 10.1007/s10147-026-03057-4 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift International Journal of Clinical Oncology, 2026. Verfasst von Miyako Kosugi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Data Science Department, Zeria Pharmaceutical Co., Ltd., Tokyo, Japan. Hauptthemen laut MEDLINE: Neoplasms, Anemia, Iron-Deficiency, Iron, Antineoplastic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ZERIA Pharmaceutical.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Anemia is one of the common complications in patients with cancer, particularly among those undergoing systemic chemotherapy. Current guidelines for chemotherapy-induced anemia (CIA) recommend anemia evaluation and treatment, including assessing iron deficiency. However, actual pre- and post- chemotherapy clinical practices in Japan remain unclear. This retrospective observational study investigated real-world CIA management.

Methods

In this descriptive study, we included patients with solid tumors who underwent antineoplastic therapy between January 2015 and March 2025. Baseline and follow-up hemoglobin (Hb) levels, transferrin saturation (TSAT), and serum ferritin levels were assessed. We also evaluated the anemia treatment status before and after chemotherapy, and changes in Hb levels following iron supplementation before chemotherapy.

Results

In total, 75,603 patients were included. At baseline, 55.1% of patients had Hb levels below the lower limit of normal, and 11% presented with moderate-to-severe anemia (Hb < 10 g/dL). Iron parameters were measured in < 10% of patients. Among them, functional iron deficiency (TSAT < 50% with ferritin ≥ 30 and ≤ 500 ng/mL) was the predominant finding, increasing from 54.8% to 61.6% after chemotherapy initiation. Nevertheless, intravenous iron therapy was prescribed in < 3% of patients. An increase in Hb levels was observed in certain patients who prescribed intravenous iron 4–8 weeks prior to chemotherapy, including those with initially low Hb levels.

Conclusion

This study demonstrated that anemia is highly prevalent in patients with cancer and worsens following chemotherapy. Additionally, iron parameters were rarely measured, and functional iron deficiency was frequently observed among the tested subgroup.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsAnemia, Iron-DeficiencyIronAntineoplastic AgentsHumansFemaleRetrospective StudiesJapanMaleAgedMiddle AgedHemoglobinsAdministration, IntravenousAdultFerritins

Stichwörter der Autor:innen

Cancer-related anemiaChemotherapy-induced anemiaFunctional iron deficiencyIntravenous ironIron-deficiency anemiaReal-world data

Substanzen

IronAntineoplastic AgentsHemoglobinsFerritins

Autor:innen und Institutionen

  • Data Science Department, Zeria Pharmaceutical Co., Ltd., Tokyo, Japan.
  • Data Science Department, Zeria Pharmaceutical Co., Ltd., Tokyo, Japan. shun-shiota@zeria.co.jp.
  • Real World Evidence Division, Pharmaceutical Division, JMDC Inc., Tokyo, Japan.
  • Division of Clinical Oncology, Hiroshima Prefectural Hospital, Hiroshima, Japan.

Förderung

  • ZERIA Pharmaceutical

Zitieren

APA

Kosugi, M., Takezawa, R., Shiota, S., Inokuchi, S., Takaya, H., & Yamauchi, M. (2026). Management of iron deficiency anemia and the role of intravenous iron supplementation in patients undergoing cancer chemotherapy: a real-world retrospective study in Japan. International Journal of Clinical Oncology. https://doi.org/10.1007/s10147-026-03057-4

Vancouver

Kosugi M, Takezawa R, Shiota S, Inokuchi S, Takaya H, Yamauchi M. Management of iron deficiency anemia and the role of intravenous iron supplementation in patients undergoing cancer chemotherapy: a real-world retrospective study in Japan. International Journal of Clinical Oncology. 2026. doi:10.1007/s10147-026-03057-4

BibTeX
@article{Kosugi2026,
  author = {Kosugi, Miyako and Takezawa, Ryo and Shiota, Shun and Inokuchi, Shoichiro and Takaya, Hirokazu and Yamauchi, Masami},
  title = {Management of iron deficiency anemia and the role of intravenous iron supplementation in patients undergoing cancer chemotherapy: a real-world retrospective study in Japan},
  journal = {International Journal of Clinical Oncology},
  year = {2026},
  doi = {10.1007/s10147-026-03057-4}
}
Kostenlos starten →